Search results for "MESH: Time Factors"

showing 8 items of 18 documents

Increased Activity of Coagulation Factor XII (Hageman Factor) Causes Hereditary Angioedema Type III

2006

International audience; Hereditary angioedema (HAE) is characterized clinically by recurrent acute skin swelling, abdominal pain, and potentially life-threatening laryngeal edema. Three forms of HAE have been described. The classic forms, HAE types I and II, occur as a consequence of mutations in the C1-inhibitor gene. In contrast to HAE types I and II, HAE type III has been observed exclusively in women, where it appears to be correlated with conditions of high estrogen levels--for example, pregnancy or the use of oral contraceptives. A recent report proposed two missense mutations (c.1032C-->A and c.1032C-->G) in F12, the gene encoding human coagulation factor XII (FXII, or Hageman factor…

MaleTime FactorsKinins030204 cardiovascular system & hematologyMESH: Founder Effect[SDV.IMM.II]Life Sciences [q-bio]/Immunology/Innate immunityLinkage Disequilibrium0302 clinical medicineMissense mutationHereditary Angioedema Type IIIGenetics(clinical)MESH: Models GeneticGenetics (clinical)MESH: Heterozygote0303 health sciencesFactor XII[SDV.MHEP.HEM]Life Sciences [q-bio]/Human health and pathology/HematologyFounder EffectMarkov ChainsPedigree3. Good healthMESH: Linkage DisequilibriumFactor XIIHereditary angioedemaFemalemedicine.symptomMESH: Factor XIIHeterozygotemedicine.medical_specialtyMESH: MutationMESH: PedigreeMESH: Bayes TheoremCoagulation Factor XIIBiology03 medical and health sciencesMESH: Markov ChainsReportInternal medicinemedicineGeneticsHumansMESH: AngioedemaAngioedema030304 developmental biologyMESH: HumansModels GeneticAngioedemaHaplotypeMESH: Time FactorsBayes TheoremHeterozygote advantageMESH: Haplotypesmedicine.diseaseMESH: KininsMESH: MaleEndocrinologyHaplotypesMutationImmunologyMESH: Microsatellite RepeatsMESH: FemaleMicrosatellite RepeatsThe American Journal of Human Genetics
researchProduct

Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study.

2009

International audience; BACKGROUND: Reports of an increased risk of lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease are controversial. We assessed this risk in a prospective observational cohort study. METHODS: 19,486 patients with inflammatory bowel disease, of whom 11,759 (60.3%) had Crohn's disease and 7727 (39.7%) had ulcerative colitis or unclassified inflammatory bowel disease, were enrolled in a nationwide French cohort by 680 gastroenterologists, who reported details of immunosuppressive therapy during the observation period, cases of cancer, and deaths. The risk of lymphoproliferative disorder was assessed according to thiopurine expos…

MaleTime FactorsMESH : Age DistributionMESH : Prospective StudiesMESH : AgedInflammatory bowel diseaseMESH: Proportional Hazards Models0302 clinical medicineMESH: Lymphoproliferative DisordersCrohn DiseaseRisk FactorsMESH: Risk FactorsMESH : PurinesMESH : FemaleProspective StudiesMESH: IncidenceProspective cohort studyMESH : Immunosuppressive AgentsMESH : Sex DistributionMESH: AgedMESH : Tumor Necrosis Factor-alphaCrohn's diseaseMESH: Middle AgedThiopurine methyltransferasebiologyMESH : Lymphoproliferative DisordersIncidenceMESH: Sex DistributionGeneral MedicineMESH: PurinesMiddle AgedMESH : AdultMESH : Colitis UlcerativeUlcerative colitisMESH : Risk FactorsMESH : Incidence3. Good health030220 oncology & carcinogenesisCohortDrug Therapy CombinationFemale030211 gastroenterology & hepatology[ SDV.MHEP.HEG ] Life Sciences [q-bio]/Human health and pathology/Hépatology and GastroenterologyFranceMESH: Immunosuppressive AgentsImmunosuppressive AgentsCohort studyMESH : Time FactorsAdultmedicine.medical_specialtyMESH : MaleMESH: Colitis UlcerativeLymphoproliferative disordersMESH : Crohn DiseaseMESH: Multivariate Analysis03 medical and health sciencesAge DistributionInternal medicinemedicineHumansMESH : Middle AgedSex DistributionMESH : FranceMESH: Age DistributionAgedProportional Hazards ModelsMESH: HumansMESH: Crohn DiseaseTumor Necrosis Factor-alphabusiness.industryMESH : Drug Therapy CombinationMESH: Time FactorsMESH : HumansMESH : Multivariate AnalysisMESH: Adult[SDV.MHEP.HEG]Life Sciences [q-bio]/Human health and pathology/Hépatology and Gastroenterologymedicine.diseaseMESH : Proportional Hazards ModelsLymphoproliferative DisordersMESH: MaleMESH: Prospective StudiesSurgeryMESH: FranceMESH: Drug Therapy CombinationPurinesMESH: Tumor Necrosis Factor-alphaMultivariate Analysisbiology.proteinColitis UlcerativebusinessMESH: Female
researchProduct

Incremental predictive value of mean platelet volume/platelet count ratio in in-hospital stroke after acute myocardial infarction.

2017

IF 2.558; International audience; Stroke is a serious complication after acute myocardial infarction (AMI) and is associated with an increased risk of death. Though the pathophysiological mechanisms are not exactly known, increased inflammation and platelet reactivity could play an important role in the occurrence of stroke during AMI. We aimed to investigate the relationship between both mean platelet volume (MPV), a parameter of platelet function, and C-reactive protein (CRP) and the occurrence of in-hospital ischemic stroke (IHS) after AMI. Data were obtained from a French regional survey for AMI that included 5976 patients admitted to an intensive care unit (ICU) between 2001 and 2010. …

MaleTime FactorsMESH : StrokeMyocardial InfarctionMESH : AgedMESH: ComorbidityComorbidityMESH: Hospitalization030204 cardiovascular system & hematologyMESH : Platelet Countlaw.inventionMESH: Proportional Hazards Models0302 clinical medicineMESH: Aged 80 and overRisk FactorslawMESH: Risk FactorsOdds Ratio[ SDV.MHEP.HEM ] Life Sciences [q-bio]/Human health and pathology/HematologyMESH : FemaleMyocardial infarctionMESH : BiomarkersStrokeMESH: Blood PlateletsAged 80 and overMESH: AgedEjection fractionMESH: Middle AgedMESH : PrognosisbiologyMESH : Mean Platelet Volume[SDV.MHEP.HEM]Life Sciences [q-bio]/Human health and pathology/HematologyHematologyGeneral MedicineMiddle AgedPrognosisIntensive care unitstrokeMESH : Risk Factors3. Good healthHospitalizationMESH: Myocardial Infarctionrisk factorplateletsMESH : ComorbidityCardiologyMESH : HospitalizationFemaleMean Platelet VolumeMESH : Time FactorsBlood Plateletsmedicine.medical_specialtyMESH : Male[SDV.BC]Life Sciences [q-bio]/Cellular BiologyAcute myocardial infarctionMESH: PrognosisMESH: StrokeC-reactive protein03 medical and health sciencesInternal medicinemedicineHumansMESH : Middle AgedMESH: Platelet Countcardiovascular diseasesRisk factorMean platelet volumeMESH : Aged 80 and overSurvival analysisAgedProportional Hazards ModelsMESH: HumansPlatelet Countbusiness.industry[ SDV.BC ] Life Sciences [q-bio]/Cellular BiologyC-reactive proteinMESH: Time FactorsMESH : HumansMESH : Blood Plateletsmedicine.diseaseMESH : Proportional Hazards ModelsMESH: Odds RatioMESH: MaleMESH: Mean Platelet Volumebiology.proteinMESH: BiomarkersMESH : Odds RatioMESH : Myocardial InfarctionbusinessMESH: FemaleBiomarkers030217 neurology & neurosurgery
researchProduct

A time series study on the effects of heat on mortality and evaluation of heterogeneity into European and Eastern-Southern Mediterranean cities: resu…

2013

Background: The Mediterranean region is particularly vulnerable to the effect of summer temperature. Within the CIRCE project this time-series study aims to quantify for the first time the effect of summer temperature in Eastern-Southern Mediterranean cities and compared it with European cities around the Mediterranean basin, evaluating city characteristics that explain between-city heterogeneity. Methods: The city-specific effect of maximum apparent temperature (Tappmax) was assessed by Generalized Estimation Equations, assuming a linear threshold model. Then, city-specific estimates were included in a random effect meta-regression analysis to investigate the effect modification by several…

Mediterranean climateMaleMESH: Urban HealthHot TemperatureTime FactorsClimateHealth Toxicology and MutagenesisVulnerability010501 environmental sciences01 natural sciencesMediterranean BasinMESH: Regression AnalysisMESH: Cause of Death0302 clinical medicineAfrica NorthernMESH: ChildCause of Death11. Sustainability030212 general & internal medicineMediterranean regionSocioeconomicsChildMESH: Aged[SDV.EE]Life Sciences [q-bio]/Ecology environmentMiddle EastMESH: Middle AgedMESH: Infant Newborn1. No povertyAge FactorsMiddle AgedMESH: ClimateMESH: Middle East/epidemiologyMESH: Infant3. Good healthGeographyMESH: Young AdultChild Preschool8. Economic growthRegression AnalysisFemaleSeasonsAdultmedicine.medical_specialtyAdolescentClimate changeHeat Stress DisordersMESH: Mediterranean Region/epidemiology03 medical and health sciencesMiddle EastYoung AdultmedicineMESH: CitiesHumansCitiesMortalityMESH: Heat Stress Disorders/mortality*0105 earth and related environmental sciencesMESH: Hot Temperature/adverse effectsAgedEstimationMESH: AdolescentMESH: Age FactorsMESH: Heat Stress Disorders/etiologyMESH: HumansPublic healthResearchMESH: Child PreschoolMESH: Time FactorsInfant NewbornUrban HealthPublic Health Environmental and Occupational HealthMESH: Africa Northern/epidemiologyInfantMESH: AdultMESH: MaleApparent temperature13. Climate actionHot temperature; Mortality; Mediterranean region; Heterogeneity; Age groups; Public Health; TIME series analysis; Older people; Public health; Unemployment statistics; Climatic changes[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologieMESH: Mortality/trends*HeterogeneityAge groupsMESH: FemaleMESH: SeasonsMedicine; Geriatrics
researchProduct

Surrogate endpoints for overall survival in digestive oncology trials: which candidates? A questionnaires survey among clinicians and methodologists

2010

Abstract Background Overall survival (OS) is the gold standard for the demonstration of a clinical benefit in cancer trials. Replacement of OS by a surrogate endpoint allows to reduce trial duration. To date, few surrogate endpoints have been validated in digestive oncology. The aim of this study was to draw up an ordered list of potential surrogate endpoints for OS in digestive cancer trials, by way of a survey among clinicians and methodologists. Secondary objective was to obtain their opinion on surrogacy and quality of life (QoL). Methods In 2007 and 2008, self administered sequential questionnaires were sent to a panel of French clinicians and methodologists involved in the conduct of …

OncologyCancer ResearchTime FactorsDigestive System Neoplasms[ SDV.CAN ] Life Sciences [q-bio]/Cancer0302 clinical medicineQuality of lifeSurveys and QuestionnairesMedicine030212 general & internal medicineMESH: Treatment OutcomeResponse rate (survey)MESH : Evidence-Based MedicineClinical Trials as TopicEvidence-Based MedicineMESH: Endpoint DeterminationMESH: Research DesignMESH : QuestionnairesMESH : Research Designlcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens3. Good healthMESH: Reproducibility of Resultsmedicine.anatomical_structureTreatment OutcomeOncologyResearch Design030220 oncology & carcinogenesisData Interpretation StatisticalMESH: Survival AnalysisMESH : Disease-Free SurvivalMESH : Endpoint DeterminationFranceMESH : Time FactorsResearch Articlemedicine.medical_specialtyMESH: Clinical Trials as TopicEndpoint DeterminationRectum[SDV.CAN]Life Sciences [q-bio]/CancerMESH : Treatment Outcomelcsh:RC254-282Disease-Free Survival03 medical and health sciences[SDV.CAN] Life Sciences [q-bio]/CancerInternal medicineGeneticsHumansMESH : Data Interpretation StatisticalMESH : FranceSurvival analysisMESH: Humansbusiness.industrySurrogate endpointMESH: Digestive System NeoplasmsMESH : Reproducibility of ResultsMESH: QuestionnairesMESH : HumansMESH: Time FactorsCancerReproducibility of ResultsMESH: Quality of LifeMESH : Quality of Lifemedicine.diseaseSurvival AnalysisMESH : Clinical Trials as TopicMESH: FranceLocalized diseaseEndpoint DeterminationMESH: Disease-Free SurvivalQuality of LifeMESH : Digestive System NeoplasmsMESH : Survival AnalysisbusinessMESH: Data Interpretation StatisticalMESH: Evidence-Based MedicineBMC Cancer
researchProduct

Computational evidence that frequency trajectory theory does not oppose but emerges from age-of-acquisition theory.

2012

International audience; According to the age-of-acquisition hypothesis, words acquired early in life are processed faster and more accurately than words acquired later. Connectionist models have begun to explore the influence of the age/order of acquisition of items (and also their frequency of encounter). This study attempts to reconcile two different methodological and theoretical approaches (proposed by Lambon Ralph & Ehsan, 2006 and Zevin & Seidenberg, 2002) to age-limited learning effects. The current simulations extend the findings reported by Zevin and Seidenberg (2002) that have shown that frequency trajectories (FTs) have limited and specific effects on word-reading tasks. Using th…

Time FactorsComputer scienceTask (project management)Learning effect0302 clinical medicineMESH: Models PsychologicalComputingMilieux_MISCELLANEOUSMESH : Models PsychologicalCognitive sciencePsycholinguisticsMESH : Neural Networks (Computer)05 social sciencesAge FactorsContrast (statistics)MESH : Artificial IntelligenceLanguage acquisition[SCCO.PSYC]Cognitive science/Psychology[SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]MESH : PsycholinguisticsCognitive psychologyMESH : Time FactorsOrder of acquisitionCognitive NeuroscienceExperimental and Cognitive PsychologyMESH: ReadingModels PsychologicalLanguage Development050105 experimental psychologyMESH: Psycholinguistics03 medical and health sciencesMESH: Neural Networks (Computer)ConnectionismArtificial IntelligenceMESH: Language DevelopmentMESH: Artificial IntelligenceHumans0501 psychology and cognitive sciencesMESH: Age FactorsMESH : Language DevelopmentMESH: HumansMESH: Time FactorsMESH : HumansMESH : ReadingWord lists by frequencyAge of AcquisitionReading[ SDV.NEU ] Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]MESH : Age FactorsNeural Networks Computer030217 neurology & neurosurgeryCognitive science
researchProduct

[Choosing a quality-of-life questionnaire].

2006

International audience; Define the objective of the questionnaire: Discrimination: do you want a questionnaire to enable you to describe the quality of life of patients or to compare the quality of life between groups of patients, for example, to determine who has improved and who has gotten worse? Assessment: do you want a questionnaire to help you measure changes over time (improvement or aggravation) in your patients? Determine the properties of instruments necessary for this objective: If the objective is discrimination, analyze: construct validity, reliability. If the objective is assessment, analyze construct validity, sensitivity to changes. Choose the general category of questionnai…

Time FactorsHealth StatusMESH : Randomized Controlled Trials as TopicMESH : Multicenter Studies as Topic[ SDV.NEU.SC ] Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]/Cognitive SciencesSurveys and QuestionnairesActivities of Daily LivingHumansMulticenter Studies as TopicMESH : Health StatusMESH: Health StatusRandomized Controlled Trials as TopicMESH: HumansMESH: QuestionnairesMESH: Activities of Daily LivingMESH: Time FactorsMESH : HumansMESH: Quality of Life[SDV.NEU.SC]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]/Cognitive SciencesMESH : QuestionnairesMESH : Follow-Up StudiesMESH: Follow-Up StudiesMESH : Quality of LifeMESH: Randomized Controlled Trials as TopicQuality of LifeMESH: Multicenter Studies as TopicMESH : Activities of Daily Living[SDV.NEU.SC] Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]/Cognitive SciencesFollow-Up StudiesMESH : Time Factors
researchProduct

Interaction of an odorant lactone with model phospholipid bilayers and its strong fluidizing action in yeast membrane

2003

International audience; Some odorant lactones are naturally present in fruits or in fermented products; they can also be used as food additives and can be produced by microorganisms at the industrial scale by biotechnological processes. Gamma-decalactone was previously shown to have antimicrobial properties. We determined by infrared spectroscopy measurements that this compound rapidly diffused into model phospholipid bilayers (within 2 min), modifying the general physical state of a dimyristoyl-L-alpha-phosphatidylcholine (DMPC) film. In vivo, the lactone strongly increased membrane fluidity in the model yeast Yarrowia lipolytica, as evaluated by fluorescence anisotropy measurements. This …

Time Factors[SDV.BIO]Life Sciences [q-bio]/BiotechnologyLipid BilayersYarrowiaMESH : Models BiologicalLactonesMESH : Spectroscopy Fourier Transform InfraredMESH: Dimyristoylphosphatidylcholinechemistry.chemical_compoundMESH : DimyristoylphosphatidylcholineSpectroscopy Fourier Transform InfraredMembrane fluidityOrganic chemistryMESH : Anti-Bacterial Agents[INFO.INFO-BT]Computer Science [cs]/BiotechnologyAntibacterial agentMESH : Spectrometry FluorescencebiologyMESH: Lipid BilayersMESH: Indicators and Reagentsfood and beveragesGeneral MedicineAnti-Bacterial AgentsMESH : LactonesMembraneBenzyl alcoholDimyristoylphosphatidylcholine[ INFO.INFO-BT ] Computer Science [cs]/BiotechnologyMESH: LactonesMESH: Spectrometry FluorescenceMESH : Time FactorsMESH : YarrowiaPhospholipid[SDV.BC]Life Sciences [q-bio]/Cellular BiologyModels BiologicalMicrobiologyMESH: Spectroscopy Fourier Transform InfraredMESH : Indicators and ReagentsMESH: Anti-Bacterial Agents[ SDV.BC ] Life Sciences [q-bio]/Cellular BiologyMESH: Time FactorsMESH: Models Biological[ SDV.BIO ] Life Sciences [q-bio]/BiotechnologyYarrowiaBiological membranebiology.organism_classificationYeastSpectrometry FluorescencechemistryIndicators and ReagentsMESH: YarrowiaMESH : Lipid BilayersFood ScienceInternational Journal of Food Microbiology
researchProduct